Saturday 17 October 2026 Export SNOA’s income statement to Excel — free account

Sonoma Pharmaceuticals, Inc.

SNOA Healthcare Drug Manufacturers Specialty & Generic

Sonoma Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $19.5 million, up 36.7% from fiscal 2025. In the quarter to June 2026, revenue grew 59.6%, EPS grew 88.2% and free cash flow grew 69.3%, each against the same quarter a year earlier.

1.13 0.02 −1.74%

Follow SNOA

Alert me

Market cap: $5.5M
P/E: 0.0×
Fwd P/E: −2.0×
Dividend yield: —
F-score: 3/9
Altman Z: −18.52
Beneish M: −1.69
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		0.38	0.35	0.18	0.22
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(10.06)	(8.16)	(6.91)	(7.29)
P/B ratio Full definition →		1.69	1.82	1.16	0.72
Price to Tangible BV Full definition →		1.69	1.82	1.16	0.72
EV/Sales Full definition →		0.20	0.21	0.07	(0.02)
EV/EBITDA Full definition →		0.00	0.00	0.00	0.40
EV/Operating CF Full definition →		(1.58)	(1.07)	(0.33)	0.20
EV/FCF Full definition →		(1.47)	(1.01)	(0.31)	0.19
Quick Ratio Full definition →		1.33	1.17	1.02	1.56
Current Ratio Full definition →		2.89	2.88	2.50	2.99
Net Debt/EBITDA Full definition →		10.08	3.98	7.54	667.25
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		1.23	1.30	1.41	1.34
Operating CF/Net income Full definition →		1.19	0.93	0.89	1.97
Capex/Depreciation Full definition →		(0.28)	(1.38)	(0.88)	(0.06)
Research and Development Expense of Revenue Full definition →		10.26%	12.81%	9.80%	9.32%
Selling, General and Administrative Expense of Revenue Full definition →		33.58%	40.72%	35.73%	31.53%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		0.70%	0.55%	2.43%	0.91%
Graham Net Nets Full definition →		0.38	0.31	0.34	1.01
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(56.44%)	(56.04%)	(88.73%)	(99.19%)
Free Cash Flow Yield Full definition →		(36.72%)	(59.64%)	(115.00%)	(56.12%)
Revenue per Share Full definition →		3.40	2.54	3.30	1.67
Operating CF per Share Full definition →		(0.39)	(0.45)	(0.31)	(0.17)
Capex per Share Full definition →		(0.01)	(0.03)	(0.02)	0.00
Free Cash Flow per Share Full definition →		(0.39)	(0.47)	(0.33)	(0.17)
Cash per Share Full definition →		1.84	1.50	1.42	1.39
Shareholders Equity per Share Full definition →		2.30	2.00	1.84	1.71
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.30	2.00	1.84	1.71
Free Cash Flow Full definition →		(0.64)	(0.81)	(0.55)	(0.65)
Working Capital Full definition →		8.18	7.93	7.27	10.82
Capital Expenditures Full definition →		(0.01)	(0.05)	(0.03)	0.00
Net Current Asset Value Full definition →		2.43	1.95	1.24	4.76
EV/EBIT Full definition →		0.00	0.00	0.00	0.36
Capex to Sales Full definition →		0.00	0.01	0.01	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		2.93	2.39	2.38	2.89
Average Payables Full definition →		1.09	1.52	1.44	2.12
Average Inventory Full definition →		3.24	3.42	3.28	3.79
Average Assets Full definition →		13.77	13.65	13.83	16.35
Average Common Equity Full definition →		4.57	4.15	3.75	5.33

Fold the line items

Columns are period end dates

Stockrow Weekly